BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27993215)

  • 21. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression.
    Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z
    Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway.
    Ao X; Yang Y; Okiji T; Azuma M; Nagai S
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33753411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].
    Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic Acute Renal Injury.
    Xu J; Ma X; Yu K; Wang R; Wang S; Liu R; Liu H; Gao H; Yu K; Wang C
    J Microbiol Immunol Infect; 2021 Jun; 54(3):404-410. PubMed ID: 31727535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNA HOTAIRM1 Promotes Immunosuppression in Sepsis by Inducing T Cell Exhaustion.
    Chen W; Liu J; Ge F; Chen Z; Qu M; Nan K; Gu J; Jiang Y; Gao S; Liao Y; Wang C; Zhang H; Miao C
    J Immunol; 2022 Feb; 208(3):618-632. PubMed ID: 35022270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
    Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
    Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
    Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment.
    Kaltenmeier C; Yazdani HO; Morder K; Geller DA; Simmons RL; Tohme S
    Front Immunol; 2021; 12():785222. PubMed ID: 34899751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.
    Orafaie A; Sadeghian H; Bahrami AR; Rafatpanah H; Matin MM
    Bioorg Med Chem; 2021 Jan; 30():115951. PubMed ID: 33360579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPLENIC INVARIANT NATURAL KILLER T CELLS PLAY A SIGNIFICANT ROLE IN THE RESPONSE TO POLYMICROBIAL SEPSIS.
    Heffernan DS; Chung CS; Ayala A
    Shock; 2023 Sep; 60(3):443-449. PubMed ID: 37493576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
    Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
    Front Immunol; 2021; 12():648420. PubMed ID: 34589081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.
    Kodumudi KN; Ramamoorthi G; Snyder C; Basu A; Jia Y; Awshah S; Beyer AP; Wiener D; Lam L; Zhang H; Greene MI; Costa RLB; Czerniecki BJ
    Front Immunol; 2019; 10():1939. PubMed ID: 31475002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cells from patients with Candida sepsis display a suppressive immunophenotype.
    Spec A; Shindo Y; Burnham CA; Wilson S; Ablordeppey EA; Beiter ER; Chang K; Drewry AM; Hotchkiss RS
    Crit Care; 2016 Jan; 20():15. PubMed ID: 26786705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice.
    Lomas-Neira J; Monaghan SF; Huang X; Fallon EA; Chung CS; Ayala A
    Front Immunol; 2018; 9():3030. PubMed ID: 30619369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of regulation of PD-1 and PD-L1 expression in sepsis.
    Zhang T; Yu-Jing L; Ma T
    Front Immunol; 2023; 14():1029438. PubMed ID: 36969168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
    Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
    Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.